SCHEMBL26116014

SCHEMBL26116014

COc1cc(OC)c(CN2C(=O)CCNC2=O)c(OC)c1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.38
ALDH1A1 P00352 4/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
MAPT P10636 1/20 0.36
PARP1 P09874 1/20 0.36
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
POLB P06746 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
TSHR P16473 1/20 0.34
HCRTR1 O43613 1/20 0.34
HCRTR2 O43614 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
BLM P54132 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23120457 0.82 ALDH1A1 (0.49) GAAALDH1A1MEN1KMT2AMAPT
SCHEMBL23120576 0.77 MEN1 (0.61) GAAALDH1A1MEN1KMT2AMAPT
Hydrochloric Acid SCHEMBL30616170 0.75 MEN1 (0.59) GAAALDH1A1MEN1KMT2AMAPT
SCHEMBL26537662 0.74 GAA (0.42) GAAALDH1A1MEN1KMT2AMAPT
SCHEMBL11481550 0.73 PARP1 (0.42) GAAALDH1A1MEN1KMT2APARP1
SCHEMBL4154483 0.69 APLNR (0.54) GAAALDH1A1MEN1KMT2AMAPT
SCHEMBL26641501 0.69 GSK3A (0.57) GAAALDH1A1MEN1KMT2AMAPT
SCHEMBL14844572 0.69 ALDH1A1 (0.49) GAAALDH1A1MEN1KMT2APOLB
SCHEMBL14252518 0.68 ADRB1 (0.53) ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL12980029 0.67 PABPC1 (0.34) GAAALDH1A1MEN1KMT2APARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250205344-A1 2,4-DIOXOTETRAHYDROPYRIMIDINYL DERATIVES AS DEGRONS IN PROTACS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2025-06-26 US disclosed
EP-4499628-A1 2,4-DIOXOTETRAHYDROPYRIMIDINYL DERIVATIVES AS DEGRONS IN PROTACS GlaxoSmithKline Intellectual Property Development Limited (GB) 2025-02-05 EP disclosed
WO-2023180388-A1 2,4-DIOXOTETRAHYDROPYRIMIDINYL DERIVATIVES AS DEGRONS IN PROTACS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2023-09-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250205344-A1 2,4-DIOXOTETRAHYDROPYRIMIDINYL DERATIVES AS DEGRONS IN PROTACS CRBN, AR, GNRHR GAA 3074/4885ALDH1A1 3146/4885MEN1 1265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.